Today: 19 March 2026
Browse Category

Stock Market 15 March 2025 - 22 March 2025

Internet Access in Kiribati: Bridging the Digital Divide Across Remote Pacific Islands

Internet Access in Kiribati: Bridging the Digital Divide Across Remote Pacific Islands

About 73,300 people in Kiribati used the internet as of January 2024, covering 54.4% of the population. The country relies entirely on satellite links for connectivity, with no submarine fiber cable in place. The East Micronesia Cable System is under construction and expected to connect Tarawa to Guam by 2025. Starlink has around 1,500 user terminals in South Tarawa, though not yet officially licensed.
22 March 2025
1 1,353 1,354 1,355

Stock Market Today

  • Soligenix Publishes HyBryte Clinical Data Validating Safety and Efficacy
    March 19, 2026, 2:04 PM EDT. Soligenix (NASDAQ: SNGX), a biopharmaceutical firm targeting rare diseases, reported the publication of clinical trial data on HyBryte (synthetic hypericin) in the peer-reviewed journal Expert Opinion on Investigational Drugs. The summary underscores HyBryte's safety profile, non-mutagenic mechanism, and demonstrated efficacy against cutaneous T-cell lymphoma (CTCL). The data supports HyBryte's potential as a first-line treatment. Soligenix continues its ongoing FLASH2 Phase 3 trial for HyBryte, with an interim analysis slated for Q2 2026. The company focuses on rare disease therapies and vaccine programs underpinned by proprietary technology. This publication bolsters investor confidence as Soligenix advances regulatory efforts toward global commercialization of HyBryte, expanding its pipeline across inflammatory and infectious diseases.
Go toTop